NMPA Approval

Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate Tablets（Ⅰ）

Approval Number

国药准字H20233988

Company上海迪赛诺医药集团股份有限公司

Registration Date

August 1, 2023

Drug Information

Generic Name

依非米替片(Ⅰ)

Dosage Form

片剂

Strength

每片含依非韦伦0.4g，拉米夫定0.3g，富马酸替诺福韦二吡呋酯0.3g

Drug Type

化学药品

Registration Date

August 1, 2023

Company Information

Applicant Company

Company Name上海迪赛诺医药集团股份有限公司

Company Address

中国（上海）自由贸易试验区张衡路1479号1幢

Manufacturing Company

Company Name上海迪赛诺医药集团股份有限公司

Company Address

中国（上海）自由贸易试验区张衡路1479号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.